• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 3. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

Introduction to Isoamyl α-Bromophenylacetate (CAS No: 92018-48-9)

Isoamyl α-Bromophenylacetate (CAS No: 92018-48-9) is a compound of significant interest in the fields of organic chemistry and materials science. This compound, also referred to as α-bromophenylacetate isoamyl ester, has been the subject of extensive research due to its unique chemical properties and potential applications in various industries. The structure of this compound consists of an isoamyl group attached to an α-bromo phenyl acetate moiety, which contributes to its reactivity and versatility in chemical reactions.

The synthesis of Isoamyl α-Bromophenylacetate involves a multi-step process that typically begins with the bromination of phenol derivatives, followed by esterification with isoamyl alcohol. Recent advancements in catalytic methods have improved the efficiency and selectivity of these reactions, making the production of this compound more sustainable and cost-effective. Researchers have also explored the use of microwave-assisted synthesis, which has shown promising results in terms of reaction time and yield.

In terms of applications, Isoamyl α-Bromophenylacetate has found utility in the pharmaceutical industry as an intermediate in drug synthesis. Its bromine atom makes it a valuable substrate for nucleophilic substitution reactions, which are critical in the development of bioactive molecules. For instance, studies have demonstrated its use in the synthesis of β-lactam antibiotics, where it serves as a key intermediate in forming the core structure of these drugs.

Beyond pharmaceuticals, this compound has also been investigated for its potential in materials science. The phenolic group in Isoamyl α-Bromophenylacetate can undergo various polymerization reactions, leading to the formation of high-performance polymers with applications in electronics and advanced materials. Recent research has focused on incorporating this compound into polyurethane formulations, resulting in materials with enhanced mechanical properties and thermal stability.

The chemical stability of Isoamyl α-Bromophenylacetate is another area that has garnered attention from scientists. Studies have shown that under certain conditions, such as high temperatures or exposure to light, the compound can undergo degradation, releasing bromine-containing byproducts. Understanding these degradation pathways is crucial for ensuring safe handling and storage practices in industrial settings.

In conclusion, Isoamyl α-Bromophenylacetate (CAS No: 92018-48-9) is a versatile compound with a wide range of applications across multiple disciplines. Its unique chemical structure and reactivity make it an invaluable tool in drug development and materials science. As research continues to uncover new synthetic methods and applications for this compound, its role in advancing technology and medicine is expected to grow significantly.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)